Related Experiment Video
Updated: Nov 8, 2025

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
A novel method for clinical risk prediction with low-quality data.
Zeyuan Wang1, Josiah Poon2, Shuze Wang3
1School of Computer Science, The University of Sydney, Australia; Real-World Study Group, Medicinovo Inc., China.
This study introduces AMI-Net3, a novel framework for clinical risk prediction that effectively handles low-quality data, including missing values and feature redundancy, by treating patients as bags of instances. The method improves prediction accuracy by learning directly from data without imputation.
Area of Science:
- Computational biology
- Machine learning in healthcare
- Data science for clinical prediction
Background:
- Real-world clinical data often suffers from low quality, including missing values, feature redundancy, and class imbalance, hindering predictive model performance.
- Existing methods struggle to systematically address these data quality issues, often introducing noise through imputation or failing to resolve challenges.
- A robust framework is needed to improve the accuracy and reliability of predictive models for clinical risks.
Purpose of the Study:
- To propose a novel framework, AMI-Net3, designed to address low-quality data challenges in clinical risk prediction.
- To develop a method that can learn directly from incomplete data without relying on imputation, thus avoiding introduced noise.
- To effectively handle correlated/redundant features and imbalanced datasets in clinical risk modeling.
Main Methods:
- Patients are represented as bags of instances (feature-value pairs), mapped to an embedding space using a proposed feature embedding method.
- A multi-instance neural network incorporating multi-head attention and attention-based multi-instance pooling is employed to manage feature correlations and identify valuable information.
- Joint end-to-end optimization of feature embedding and the neural network, with auxiliary supervision and focal loss functions, is utilized to handle imbalanced labels.
Main Results:
- AMI-Net3 demonstrates effectiveness in clinical risk prediction tasks, including adverse drug reactions, schizophrenia relapse, and invasive fungal infections.
- The framework successfully mitigates the negative impact of missing data by learning directly from instances.
- Experimental results show the superiority of AMI-Net3 over competitive baseline methods on real-world datasets.
Conclusions:
- AMI-Net3 provides a systematic and effective approach to overcome data quality limitations in clinical risk prediction.
- The proposed method offers a robust solution for handling missing data, feature redundancy, and class imbalance in healthcare predictive modeling.
- This framework has the potential to significantly improve the reliability and accuracy of predictive models in real-world clinical settings.
Related Concept Videos
Relative Risk
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
Statistical Methods for Analyzing Epidemiological Data
Kaplan-Meier Approach
Statistical Software for Data Analysis and Clinical Trials

